Dragos Dinu, CEO of the main group in the pharmaceutical industry, A&D Pharma, is about to leave the company following talks with shareholders regarding results and performance, according to sources from the industry. Dinu, who has held this position with A&D Pharma for six years, has been faced with a dramatic fall in the value of the company's shares in London. In terms of the company's financial results, despite a 28% sales increase, the net profit dropped 92%. According to the quoted sources, two of the shareholders, Ludovic Robert and Walid Abboud have even become involved in the company's day-to-day activity. A&D Pharma, listed on the London Stock Exchange in 2006, with a market value of over 500 million euros at the beginning of the year, is worth 71 million euros at present, after the share price took a plunge.
Pentru alte știri, analize, articole și informații din business în timp real urmărește Ziarul Financiar pe WhatsApp Channels
